Figure 1From: Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens Overview of the design for the RNA precision validation study. Five pooled breast tumor RNA samples were tested across several sites, operators, reagent lots, and runs.Back to article page